Shopping Cart
Remove All
Your shopping cart is currently empty
Istaroxime hydrochloride (PST2744 hydrochloride) is a Na+/K+-ATPase inhibitor and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator, a novel positive inotropic compound that can be used to study acute heart failure.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $134 | 5 days | 5 days | |
| 5 mg | $229 | 5 days | 5 days | |
| 10 mg | $376 | 5 days | 5 days | |
| 50 mg | $789 | 6-8 weeks | 6-8 weeks | |
| 100 mg | $1,180 | 6-8 weeks | 6-8 weeks | |
| 1 mL x 10 mM (in DMSO) | $252 | 5 days | 5 days |
| Description | Istaroxime hydrochloride (PST2744 hydrochloride) is a Na+/K+-ATPase inhibitor and sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA 2) activator, a novel positive inotropic compound that can be used to study acute heart failure. |
| Targets&IC50 | Na+, K+-ATPase:0.11 μM, Na+, K+-ATPase (guinea-pig kidney):8.5 μM, Na+, K+-ATPase (dog kidney):0.43 μM |
| In vitro | Istaroxime hydrochloride acts as a positive inotropic drug by inhibiting Na+,K+-ATPase. [1] The IC50 value of Istaroxime hydrochloride for inhibition of Na+/K+-ATPase activity in dog kidney was 0.43 μM. In guinea-pig kidney tissue preparations, the potency of Istaroxime hydrochloride for inhibition of Na+/K+-ATPase activity was 8.5 μM. [2] |
| In vivo | Istaroxime hydrochloride progressively elevated +dP/dtmax throughout the infusion period, achieving an 80% effect at a cumulative dose of 1.89 ± 0.37 mg/kg (ED80) and reaching a peak effect of 140 ± 3.5% at a dose increase to 4.88 ± 0.6 mg/kg (EDmax). [2] |
| Synonyms | ST-2744 hydrochloride, PST-2744 hydrochloride, PST2744 hydrochloride, PST 2744 hydrochloride, Istaroxime HCl |
| Molecular Weight | 396.95 |
| Formula | C21H33ClN2O3 |
| Cas No. | 374559-48-5 |
| Smiles | C[C@@]12[C@@]3([C@]([C@]4([C@](C)(CC3)C(=O)CC4)[H])(CC(=O)[C@]1(CC(=NOCCN)CC2)[H])[H])[H].Cl |
| Relative Density. | no data available |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: 20 mg/mL (50.38 mM), Sonication is recommended. DMSO: 40 mg/mL (100.77 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2 mg/mL (5.04 mM), Sonication is recommeded. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | ||||||||||||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||||||||||||
H2O/DMSO
DMSO
| |||||||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.